AKT1 and neuroblastoma: Interestingly, CBN also displays an inhibitory role in AKT pathway in IMR-5 neuroblastoma cells, despite it attenuating CBR2 expression (Figure 2G), which may implicate a receptor-independent suppression in AKT pathway.